Second allogeneic transplants for leukemia using blood instead of bone marrow as a source of hemopoietic cells

Bone Marrow Transplantation

Volumn 18, Issue 3, 1996, Pages 501-505

  Russell, J A ^a,b,c   Bowen, T ^c   Brown, C ^a,b   Luider, J ^a   Ruether, J D ^a,b   Stewart, D ^a,b   Jorgenson, K ^c   Coppes, M J ^c   Turner, A R ^d   Larratt, L ^d   Chaudhry, A ^a,b   Booth, K ^c   Poon, M C ^a   Klassen, J ^a  

^a FOOTHILLS HOSPITAL   (Canada)

^b TOM BAKER CANCER CENTRE   (Canada)

^c ALBERTA CHILDREN'S HOSPITAL   (Canada)

^d CROSS CANCER INSTITUTE   (Canada)

Author keywords

Peripheral blood stem cell; Second transplants

Indexed keywords

CYCLOSPORIN A; FOLINIC ACID; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DONOR; FEMALE; GRAFT VERSUS HOST REACTION; GRANULOCYTE; HUMAN; LEUKAPHERESIS; LEUKEMIA; MALE; MORTALITY; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; RELAPSE; STEM CELL TRANSPLANTATION; SURVIVAL; THROMBOCYTE COUNT;

ADOLESCENT; ADULT; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA; MALE; MIDDLE AGED; TRANSPLANTATION, HOMOLOGOUS;

EID: 10144243316     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Russell NH, Hunter AE. Peripheral blood stem cells for allogeneic transplantation. Bone Marrow Transplant 1994; 13: 353-355.
2. Russell JA, Luider J, Weaver M et al. Collection of progenitor cells for allogeneic transplantation from peripheral blood of normal donors. Bone Marrow Transplant 1995; 15: 111-115.
3. Schmitz N, Dreger P, Suttorp M et al. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 1995; 85: 1666-1672.
4. Bensinger WI, Weaver CH, Appelbaum FR et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 1995; 85: 1655-1658.
5. Goldman JM. Peripheral blood stem cells for allografting. Blood 1995; 85: 1413-1416.
6. Azevedo WM, Aranha FJP, Gouvea JV et al. Allogeneic transplantation with blood stem cells mobilized by rh-G-CSF for hematological malignancies. Bone Marrow Transplant 1995; 16: 647-653.
7. Körbling M, Przepiorka D, Huh YO et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 1995; 85: 1659-1665.
8. Russell JA, Brown C, Bowen T et al. Allogeneic blood cell transplants for hematological malignancy: preliminary comparison of outcomes with bone marrow transplantation. Bone Marrow Transplant 1996; 17: 703-708.
9. Radich JP, Sanders JE, Buckner CD et al. Second allogeneic marrow transplantation for patients with recurrent leukaemia after initial conditioning with total-body irradiation containing regimens. J Clin Oncol 1993; 11: 304-313.
10. Barrett J. Management of relapse after bone marrow transplantation. In: Treleaven J, Barrett J (eds). Bone Marrow Transplantation in Practice. Churchill Livingstone: Edinburgh, 1992, pp 349-352.
11. Antin JH. Graft-versus-leukemia: no longer an epiphenomenon. Blood 1993; 82: 2273-2277.
12. Giralt SA, Champlin RE. Leukemia relapse after allogeneic bone marrow transplantation: a review. Blood 1994; 84: 3603-3612.
13. Shing MMK, Vowels M. Role of second bone marrow transplants. Bone Marrow Transplant 1993; 12: 21-25.
14. Mrsic M, Horowitz MM, Atkinson K et al. Second HLA-identical sibling transplants for leukemia recurrence. Bone Marrow Transplant 1992; 9: 269-275.
15. Russell JA, Woodman RC, Poon M-C et al. Addition of low-dose folinic acid to a methotrexate/cyclosporin regimen for prevention of acute graft-versus-host disease. Bone Marrow Transplant 1994; 14: 397-401.
16. Barrett J. Graft-versus-host disease. In: Treleaven J, Barrett J (eds). Bone Marrow Transplantation in Practice. Churchill Livingstone: Edinburgh, 1992, pp 257-272.
17. Gaiger A, Mannhalter C, Hinterberger W et al. Detection of engraftment and mixed chimerism following bone marrow transplantation using PCR amplification of a highly variable region-variable number of tandem repeats (VNTR) in the von Willebrand factor gene. Ann Hematol 1991; 63: 227-228.
18. Drobyski WR, Keever CA, Roth MS et al. Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukaemia after allogeneic bone marrow transplantation: effect of a defined T cell dose. Blood 1993; 82: 2310-2318.
19. Kolb H-J, Schattenberg A, Goldman JM et al. Graft-versus-leukemia effect of donor leukocyte transfusions in marrow grafted patients. Blood 1995; 86: 2041-2050.
20. Weaver CH, Buckner CD, Longin K et al. Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor. Blood 1993; 82: 1981-1984.
21. + Thy-1 dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease. Blood 1995; 86: 2842-2848.
22. Martinez JA, Picon I, Carral A et al. Allogeneic peripheral blood progenitor cells mobilized by G-CSF (filgrastim) for a second transplant in a patient with acute myeloid leukemia in relapse. Bone Marrow Transplant 1995; 15: 149-151.
23. Bernasconi P, Alessandrino EP, Calera D et al. Intensive chemotherapy followed by donor PBSC in ANLL relapsed after allogeneic BMT. Bone Marrow Transplant 1995; 15: 643-645.
24. Szer J, Grigg AP, Phillips GL, Sheridan WP. Donor leucocyte infusions after chemotherapy for patients relapsing with acute leukaemia following allogeneic BMT. Bone Marrow Transplant 1993; 11: 109-111.
25. Mortimer J, Blinder MA, Schulman S et al. Relapse of acute leukemia after marrow transplantation: natural history and results of subsequent therapy. J Clin Oncol 1989; 7: 50-57.
26. Dreger P, Suttorp M, Haferlach T et al. Allogeneic granulocyte colony-stimulating factor mobilised peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation. Blood 1993; 81: 1404-1409.